The activity of Src-family kinases (SFKs), which phosphorylate immunoreceptor tyrosine-based 12 activation motifs (ITAMs), is critical factor regulating myeloid-cell activation. In a previous paper 13 (Freedman et al., 2015) we showed in macrophages that the SFK LynA is uniquely susceptible to rapid 14 ubiquitin-mediated degradation, functioning as a rheostat regulating ITAM signaling. We now report the 15 mechanism by which LynA is preferentially targeted for degradation and how cell specificity is built into 16 the LynA rheostat. Using genetic and biochemical analysis, we found that the E3 ubiquitin ligase c-Cbl 17 preferentially targets LynA via tyrosine 32 in its unique insert region. This orthogonal mode of c-Cbl 18 recognition depresses the steady-state level of macrophage LynA. Mast cells, however, express little c-
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(20) and confirm that the unique sensitivity of LynA to rapid degradation is preserved in the Jurkat 150 model. We hypothesized that the targeting site in LynA must lie within the unique-region insert 151 (residues 23-43) lacking in LynB (34, 35), which contains a tyrosine phosphorylation site (Tyr32) (36), a 152 predicted ubiquitination site (Lys40) (UbPred, 37), and a predicted threonine phosphorylation site 153 (Thr27) (NetPhos 3.1, 38) ( Figure 3D ).
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Substituting LynA Tyr32 with either alanine or phenylalanine completely blocked its rapid degradation 155 ( Figure 3E ), reducing the depletion after 5 min 3-IB-PP1 from 40% (wt) to 10% (LynA Y32A ) or 8% LynB (teal, dotted), LynA K40R (dark gray), LynA T27A (light gray), or LynA Y32F (orange 
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As in BMDMs, the efficiency of Lyn degradation also affects its steady-state expression in Jurkat cells.
183
LynB is 2-and LynA Y32A 3-fold more highly expressed than wild-type LynA, LynA K40R , or LynA T27A in 184 resting cells, resulting in 3-to 4-fold more protein remaining after 20 min treatment with 3-IB-PP1 Cbl-family expression on LynA in the two cell types remains unknown. We generated bone-marrow-260 derived mast cells from Csk AS mice (hereafter referred to as "mast cells") and performed surface marker Figure 6D) and an increase in steady-state 292 expression of LynA (30% higher than in resting BMDMs) ( Figure 6E) , resulting in 3-4x more LynA 293 protein in mast cells than in resting BMDMs and 2x more than in primed BMDMs between 3 and 5 min 294 of 3-IB-PP1 treatment. Mast cells also had a stronger signaling response to 3-IB-PP1. Although the 295 kinetics of Erk phosphorylation in mast cells varied among experiments, the fold increase in pErk1/2 in 296 the first 5 min of 3-IB-PP1 treatment was consistently higher than in macrophages, even primed 297 BMDMs (40x pErk increase in mast cells compared with 14x in primed BMDMs and no significant 298 increase in resting BMDMs) ( Figure 6F) . We therefore conclude that c-Cbl expression tunes the 
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We have shown that SFK activity is required for LynA degradation, and LynA Tyr32 is a predicted 341 substrate for Hck (NetPhos 3.1, 38) in addition to EGFR. It is therefore tempting to speculate that LynA
342
Tyr32 is a site of autophosphorylation, since the SFKs Lck and Fyn cannot mediate the degradation of 
